Furthermore, IGN523 has been shown to trigger caspase‐3 and caspase‐7‐mediated apoptosis in tumor cells, while also enhancing lysosomal penetration into tumors by forming a complex with CD98 and anchoring with LAMP‐1 (for more details about clinical trial of this section, see Table 4) [322]. This evidence concerns the gene SLC3A2 and neoplasm.